• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Sean Whooley

FDA approves Medtronic’s Onyx Frontier drug-eluting coronary stent

May 13, 2022 By Sean Whooley

Medtronic logo updated

Medtronic (NYSE:MDT) announced today that it received FDA approval for its Onyx Frontier drug-eluting stent (DES). Onyx Frontier, the latest iteration of Medtronic’s Resolute DES family, was designed to leverage the same stent platform as Resolute with an enhanced delivery system for improving deliverability and increasing acute performance, even in the most challenging of cases. […]

Filed Under: Cardiovascular, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Regulatory/Compliance, Vascular Tagged With: FDA, Medtronic

Medtronic completes Intersect ENT acquisition

May 13, 2022 By Sean Whooley

Medtronic Intersect ENT

Medtronic (NYSE:MDT) announced that it completed its previously announced $1.1 billion acquisition of Intersect ENT (Nasdaq:XENT). Fridley, Minnesota-based Medtronic announced in August 2021 that it would acquire all outstanding shares of the Menlo Park, Calif.-based sinus implant maker for $28.25 per share in an all-cash transaction. As a result of the transaction, Medtronic acquires Intersect ENT’s Propel and Sinuva drug-eluting […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Implants, Mergers & Acquisitions, Otolaryngology Ear, Nose & Throat Tagged With: Intersect ENT Inc., Medtronic

Abbott announces availability of Xience Skypoint drug-eluting stent in extended sizes

May 12, 2022 By Sean Whooley

Abbott Xience Skypoint

Abbott (NYSE:ABT) announced today that its Xience Skypoint drug-eluting stent platform is now available globally. Xience Skypoint has received FDA approval, the CE mark, and PMDA approval in Japan for the broadest expansion with the availability of extended sizes of 4.5 mm and 5 mm offerings. According to Abbott, Xience Skypoint stents are now the […]

Filed Under: Auto-injectors, Business/Financial News, Cardiovascular, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Vascular Tagged With: abbott

Here’s what’s next for Insulet after the launch of Omnipod 5, CEO change

May 12, 2022 By Sean Whooley

Insulet Eric Benjamin DeviceTalks Boston 2022

The future for Insulet (Nasdaq:PODD) has a different look than it did about a week ago. A massive shake-up at the executive level came on May 5 when Shacey Petrovic announced she would step down as president and CEO for personal reasons. Petrovic will stay on as a board member at the Acton, Massachusetts-based automated […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Pharmaceuticals, Technology Tagged With: Insulet, Personnel, Personnel Moves

Senseonics beats The Street in Q1 following Eversense E3 launch

May 11, 2022 By Sean Whooley

Senseonics Eversense E3 Ascensia Diabetes Care

Senseonics (NYSE:SENS) posted first-quarter results that topped the consensus revenue forecast on Wall Street. The Germantown, Maryland-based company posted profits of $86.7 million, or 19¢ per share, on sales of $2.5 million for the three months ended March 31, 2022, for a massive bottom-line gain from losses of $249.5 million this time last year despite […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Patient Monitoring, Technology, Wall Street Beat Tagged With: Ascensia Diabetes Care, Senseonics

ICU Medical beats The Street in Q1

May 10, 2022 By Sean Whooley

ICU Medical - updated

ICU Medical (Nasdaq:ICUI) reported first-quarter results that came in ahead of the consensus earnings per share forecast. The San Clemente, California-based company yesterday evening posted losses of $38.1 million, or $1.61 per share, on sales of $543.1 million for the three months ended March 31, 2022, for a bottom-line slide into the red on sales […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Vascular, Wall Street Beat Tagged With: ICU Medical, Smiths Medical

Shacey Petrovic to step down as Insulet CEO, ResMed exec Jim Hollingshead to take role

May 5, 2022 By Sean Whooley

Insulet CEO Shacey Petrovic

Insulet (Nasdaq:PODD) announced today that President and CEO Shacey Petrovic will step down for personal family reasons. Petrovic will step down from her position effective June 1, 2022, but will continue to serve on the company’s board. She will also serve as an advisor to the company through May 2023 to support the leadership transition […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Personnel Tagged With: Insulet, Personnel, Personnel Moves

Digital therapeutics open up new opportunities in medicine

May 5, 2022 By Sean Whooley

Pear Therapeutics reSET_Check_In (1)

A wide range of companies are aiming to make waves through digital therapeutic offerings, and each is doing things differently. “We are seeing tremendous momentum for the DTx industry, with more and more products coming to market and gaining commercial coverage and recent signals from the White House and Congress demonstrating their interest and recognition […]

Filed Under: Business/Financial News, Neurological, Technology Tagged With: Better Therapeutics, dariohealth, Pear Therapeutics, sanofi

Insulet posts Street-beating Q1 as Omnipod 5 rollout is ‘progressing very well’

May 5, 2022 By Sean Whooley

Insulet Omnipod 5 Dexcom G6

Insulet (Nasdaq: PODD) reported first-quarter results that topped the consensus forecast, at the same time that it announced its CEO Shacey Petrovic plans to step down for personal family reasons. The Acton, Massachusetts-based automated insulin technology developer posted profits of $27.8 million, or 40¢ per share, on sales of $295.4 million for the three months […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Insulet

How DeepWell is developing video games as tools for treating medical conditions

May 5, 2022 By Sean Whooley

DeepWell Digital Therapeutics Mike Wilson Ryan Douglas

Imagine playing a video game where you are a wizard fighting for good in a magical realm.  You must master control of your mind and body to increase your powers and abilities, creating a forcefield shielding you from enemies and strengthening your counterattack.   In these moments of high anxiety, more control makes you more powerful, […]

Filed Under: Business/Financial News, Featured, Neurological, Technology Tagged With: DeepWell Digital Therapeutics

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 70
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS